AI Article Synopsis

  • RalA and RalB proteins play critical roles in Ras signaling related to cancer, specifically in lung cancer cell invasion.
  • TGFβ triggers epithelial-mesenchymal transition (EMT) in A549 cells, enhancing their movement without breaking down proteins, by activating the Rho/ROCK pathway that remodels the extracellular matrix.
  • RalB is essential for this matrix deformation and cell dissemination, working through the RhoGEF GEF-H1 and the Exocyst complex, showing a new way that RalB influences cancer cell invasion.

Article Abstract

RalA and RalB proteins are key mediators of oncogenic Ras signaling in human oncogenesis. Herein we investigated the mechanistic contribution of Ral proteins to invasion of lung cancer A549 cells after induction of epithelial-mesenchymal transition (EMT) with TGFβ. We show that TGFβ-induced EMT promotes dissemination of A549 cells in a 2/3D assay, independently of proteolysis, by activating the Rho/ROCK pathway which generates actomyosin-dependent contractility forces that actively remodel the extracellular matrix, as assessed by Traction Force microscopy. RalB, but not RalA, is required for matrix deformation and cell dissemination acting via the RhoGEF GEF-H1, which associates with the Exocyst complex, a major Ral effector. Indeed, uncoupling of the Exocyst subunit Sec5 from GEF-H1 impairs RhoA activation, generation of traction forces and cell dissemination. These results provide a novel molecular mechanism underlying the control of cell invasion by RalB via a cross-talk with the Rho pathway.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495419PMC
http://dx.doi.org/10.1038/srep11759DOI Listing

Publication Analysis

Top Keywords

rhogef gef-h1
8
a549 cells
8
cell dissemination
8
ralb
4
ralb regulates
4
regulates contractility-driven
4
contractility-driven cancer
4
dissemination
4
cancer dissemination
4
dissemination tgfβ
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!